Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Keratosis × 3-ingenyl angelate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 42 Melanosis 3 Warts 2 Carcinoma, Basal Cell 2 Keratosis, Seborrheic 1 Keratosis 1 Facies 1 Condylomata Acuminata 1

Interventions

tirbanibulin 3 Imiquimod 3 Cryotherapy 2 methyl 5-aminolevulinate 1 Tomography, Optical Coherence 1 Ointments 1 Fluorouracil 1 BF-200 ALA 1 3-ingenyl angelate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡